TD Cowen analyst Joseph Thome raised the firm’s price target on Ardelyx to $12 from $11 and keeps a Buy rating on the shares. The firm said they reported revenue of $46MM solidly above consensus of $36MME and the beat was driven by higher than anticipated Xphozah sales of $15.2MM vs. consensus of $6.5MME
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX:
- Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
- Ardelyx price target lowered to $13 from $14 at Citi
- Ardelyx call volume above normal and directionally bullish
- Krispy Kreme upgraded, Altice USA downgraded: Wall Street’s top analyst calls
- Ardelyx initiated with an Outperform at Leerink